Latest news
MoonLake Announces Positive Topline Results from the Phase 3 IZAR-1 Trial of Sonelokimab in Psoriatic Arthritis Demonstrating Significant Improvements Across all Clinical Endpoints, and Reports Second Quarter 2026 Financial Results - The Manila TimesThe Manila Times · Mon, 10 Aug 2026 11:19:23 GMTAbCellera Announces Positive Top-Line Phase 2 Clinical Trial Results for ABCL635, Demonstrating Significant Reduction in Frequency and Severity of Vasomotor Symptoms and a Favorable Tolerability Profile - MorningstarMorningstar · Mon, 10 Aug 2026 11:00:00 GMTEyedaptic Announces Positive Clinical Results Presented at American Retina Forum National Meeting - EIN PresswireEIN Presswire · Fri, 07 Aug 2026 13:00:00 GMTAnnexon Announces Positive Clinical Outcomes from GBS FORWARD Study on Tanruprubart - Kalkine MediaKalkine Media · Thu, 06 Aug 2026 17:44:27 GMTJupiter Endovascular Announces Positive Results From SPIRARE II Pivotal Trial - Medical Product OutsourcingMedical Product Outsourcing · Wed, 05 Aug 2026 19:58:01 GMTRocket Pharmaceuticals Announces Positive Clinical Safety Update from Initial Three Patients Treated with RP-A501 Under Modified Phase 2 Protocol for Danon Disease - Business WireBusiness Wire · Mon, 03 Aug 2026 11:00:00 GMTClearmind's CMND-100 trial reaches 160 mg with no serious adverse events - Stock TitanStock Titan · Thu, 30 Jul 2026 12:30:00 GMTMainstay Medical Announces Positive Coverage Decision for ReActiv8® from Highmark Inc. - Ortho Spine NewsOrtho Spine News · Tue, 28 Jul 2026 18:38:14 GMT